The Bill & Melinda Gates Foundation selected Susan Desmond-Hellmann, M.D., M.P.H. as its next chief executive officer. Dr. Desmond-Hellmann is currently the chancellor of the University of California, San Francisco (UCSF), and will assume her role on May 1, 2014. An oncologist by training, Desmond-Hellmann is “a recognized leader on issues of higher education, public health, drug development, regulatory innovation and health policy. She has led UCSF since August 2009, when she became the first woman to serve as the university’s chancellor, overseeing all aspects of the university and medical center’s strategy, academic programs and operations. She has extensive experience in product development, and a deep understanding of how to bridge applied research to delivery of product. Prior to her tenure at UCSF, she was President of Product Development at Genentech, where she led the development and introduction of two of the first gene-targeted therapies for cancer, Avastin and Herceptin.” Desmond-Hellmann also served as a member of Genentech’s executive committee, beginning in 1996. She sits on the boards of directors of Proctor and Gamble and Facebook, and was previously a member of the Federal Reserve Bank of San Francisco’s Economic Advisory Council. Desmond-Hellmann will take over from Jeff Raikes, who announced his retirement from the foundation in September 2013 after five years as CEO.

http://www.gatesfoundation.org/Media-Center/Press-Releases/2013/12/Susan-Desmond-Hellmann-Named-Chief-Executive-Officer-of-the-Bill-and-Melinda-Gates-Foundation